Lumos Diagnostics is attending the Texas Nurse Practitioners Annual Conference in Galveston from September 24 to 27.
Public source
Publisher name
Public post
Lumos Diagnostics is headed to the Texas Nurse Practitioners Annual Conference in Galveston, September 24–27! Stop by Booth 523 to learn how FebriDx® can help you win th…
Company
Lumos Diagnostics
Lumos (ASX:LDX) develops, manufactures and commercializes custom, rapid point-of-care diagnostic technologies
- Industry
- Biotechnology Research
- Location
- Carlsbad, US
- Company size
- 51–200 employees
About Lumos Diagnostics
Lumos Diagnostics (ASX:LDX) specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.
See moreLatest activity
Latest activity from Lumos Diagnostics
3 signals
Presence & Recognition
Lumos Diagnostics is attending the Texas Nurse Practitioners Annual Conference in Galveston, Texas from September 24 to 27.
Presence & Recognition
Lumos Diagnostics participated in a webinar with the Dallas-Fort Worth Hospital Council discussing FebriDx® for acute respiratory infections.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Lumos Pharma
Lumos Pharma is exhibiting at Booth 15 at the ESPE Annual meeting in Marseille, France.
Presence & Recognition
MX3 Diagnostics
MX3 Diagnostics is attending the SportNXT event in Melbourne next week.
Presence & Recognition
Luminex
Luminex is exhibiting at Biomarkers, CDx & Precision Medicine US in San Diego from September 23-24, Booth #11, featuring xMAP Technology.
Presence & Recognition
Diamidex
Diamidex will be exhibiting at the 11th International Conference on Legionella in Zurich from September 7 to 11.
Presence & Recognition
Galaxy Diagnostics, Inc.